EileenO'ReillyMD

Clinical Trials

• Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2003 May 01

  Completed

  Phase 1

• S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer Start of enrollment: 2004 Jan 01

  Completed

  Phase 3

• Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer Start of enrollment: 2006 Mar 01

  Completed

  Phase 2

• Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery Start of enrollment: 2007 Oct 01

  Completed

  Phase 2

• Cardiopulmonary Resuscitation (CPR) Video to Enhance Advance Care Planning in Advanced Upper Gastrointestinal Cancer Patients Start of enrollment: 2010 Apr 01

  Completed

• Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma Start of enrollment: 2011 Apr 01

  Completed

  Phase 2

• Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2012 May 15

  Active, not recruiting

  Phase 2

• A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2012 Oct 01

  Completed

  Phase 1, Phase 2

• Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer Start of enrollment: 2014 Nov 17

  Completed

  Phase 1

• Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection Start of enrollment: 2014 Sep 12

  Completed

  Not Applicable

• A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies Start of enrollment: 2019 Nov 06

  Recruiting

  Phase 1

• A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy Start of enrollment: 2020 Dec 18

  Recruiting

  Phase 2

• Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2021 Aug 09

  Active, not recruiting

  Phase 1

• A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors Start of enrollment: 2021 Oct 04

  Active, not recruiting

  Phase 1

• Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer Start of enrollment: 2020 Aug 14

  Active, not recruiting

  Phase 1, Phase 2

  Roles: Contact, Principal Investigator

• A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer Start of enrollment: 2018 Mar 07

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Start of enrollment: 2022 Dec 15

  Terminated

  Phase 1

  Roles: Contact

• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) Start of enrollment: 2022 Nov 30

  Recruiting

  Phase 1, Phase 2

  Roles: Contact, Principal Investigator

• PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 Start of enrollment: 2023 Feb 10

  Recruiting

  Phase 1

  Roles: Contact

• A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer Start of enrollment: 2023 Dec 05

  Recruiting

  Phase 2

  Roles: Contact

• Join now to see all